150 related articles for article (PubMed ID: 1675658)
1. Differentiation of oka varicella vaccine strain from wild varicella-zoster virus strains isolated from vaccinees and household contact.
Shiraki K; Horiuchi K; Asano Y; Yamanishi K; Takahashi M
J Med Virol; 1991 Feb; 33(2):128-32. PubMed ID: 1675658
[TBL] [Abstract][Full Text] [Related]
2. Analysis of varicella-zoster virus DNAs of clinical isolates by endonuclease HpaI.
Hayakawa Y; Yamamoto T; Yamanishi K; Takahashi M
J Gen Virol; 1986 Sep; 67 ( Pt 9)():1817-29. PubMed ID: 3018125
[TBL] [Abstract][Full Text] [Related]
3. New method of differentiating wild-type varicella-zoster virus (VZV) strains from Oka varicella vaccine strain by VZV ORF 6-based PCR and restriction fragment length polymorphism analysis.
Takayama M; Takayama N
J Clin Virol; 2004 Feb; 29(2):113-9. PubMed ID: 14747030
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
[TBL] [Abstract][Full Text] [Related]
5. Restriction fragment differences between the genomes of the Oka varicella vaccine virus and American wild-type varicella-zoster virus.
Adams SG; Dohner DE; Gelb LD
J Med Virol; 1989 Sep; 29(1):38-45. PubMed ID: 2573686
[TBL] [Abstract][Full Text] [Related]
6. The safety profile of varicella vaccine: a 10-year review.
Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
[TBL] [Abstract][Full Text] [Related]
7. Molecular diagnosis of zoster post varicella vaccination.
Sauerbrei A; Uebe B; Wutzler P
J Clin Virol; 2003 Jul; 27(2):190-9. PubMed ID: 12829041
[TBL] [Abstract][Full Text] [Related]
8. Analysis of United Kingdom wild-type strains of varicella-zoster virus: differentiation from the Oka vaccine strain.
Hawrami K; Breuer J
J Med Virol; 1997 Sep; 53(1):60-2. PubMed ID: 9298733
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of clinical varicella-zoster strains from India and differentiation from the oka vaccine strain.
Kaushik KS; Lahiri KK; Chumber SK; Gupta RM; Kumar S; Kapila K; Karade S
Jpn J Infect Dis; 2008 Jan; 61(1):65-7. PubMed ID: 18219137
[TBL] [Abstract][Full Text] [Related]
10. Attenuation and laboratory markers of the Oka-strain varicella-zoster virus.
Takahashi M; Hayakawa Y; Shiraki K; Yamanishi K; Asano Y; Ozaki T
Postgrad Med J; 1985; 61 Suppl 4():37-46. PubMed ID: 3014476
[TBL] [Abstract][Full Text] [Related]
11. Herpes zoster in three healthy children immunized with varicella vaccine (Oka/Biken); the causative virus differed from vaccine strain on PCR analysis of the IV variable region (R5) and of a PstI-site region.
Na GY
Br J Dermatol; 1997 Aug; 137(2):255-8. PubMed ID: 9292076
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of wild-type varicella-zoster strains from India and the Oka vaccine strain using a VZV open reading frame - 62 based PCR-RFLP technique.
Kaushik KS; Lahiri KK; Kapila K; Kumar S; Gupta RM; Karade S
Braz J Infect Dis; 2008 Aug; 12(4):313-5. PubMed ID: 19030732
[TBL] [Abstract][Full Text] [Related]
13. Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR.
Loparev VN; Argaw T; Krause PR; Takayama M; Schmid DS
J Clin Microbiol; 2000 Sep; 38(9):3156-60. PubMed ID: 10970349
[TBL] [Abstract][Full Text] [Related]
14. Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child.
Uebe B; Sauerbrei A; Burdach S; Horneff G
Eur J Pediatr; 2002 Aug; 161(8):442-4. PubMed ID: 12172829
[TBL] [Abstract][Full Text] [Related]
15. Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster.
Sauerbrei A; Rubtcova E; Wutzler P; Schmid DS; Loparev VN
J Clin Microbiol; 2004 Dec; 42(12):5604-8. PubMed ID: 15583288
[TBL] [Abstract][Full Text] [Related]
16. Nanopore sequencing in distinguishing between wild-type and vaccine strains of Varicella-Zoster virus.
Fukuda Y; Suzuki T; Iwata KI; Haruta K; Yamaguchi M; Torii Y; Narita A; Muramatsu H; Takahashi Y; Kawada JI
Vaccine; 2024 Apr; 42(11):2927-2932. PubMed ID: 38548526
[TBL] [Abstract][Full Text] [Related]
17. Viral strain identification in varicella vaccinees with disseminated rashes.
LaRussa P; Steinberg SP; Shapiro E; Vazquez M; Gershon AA
Pediatr Infect Dis J; 2000 Nov; 19(11):1037-9. PubMed ID: 11099082
[TBL] [Abstract][Full Text] [Related]
18. Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR.
Campsall PA; Au NH; Prendiville JS; Speert DP; Tan R; Thomas EE
J Clin Microbiol; 2004 Apr; 42(4):1409-13. PubMed ID: 15070981
[TBL] [Abstract][Full Text] [Related]
19. Biologic and biophysical markers of a live varicella vaccine strain (Oka): identification of clinical isolates from vaccine recipients.
Hayakawa Y; Torigoe S; Shiraki K; Yamanishi K; Takahashi M
J Infect Dis; 1984 Jun; 149(6):956-63. PubMed ID: 6330239
[TBL] [Abstract][Full Text] [Related]
20. Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world.
LaRussa P; Steinberg S; Arvin A; Dwyer D; Burgess M; Menegus M; Rekrut K; Yamanishi K; Gershon A
J Infect Dis; 1998 Nov; 178 Suppl 1():S64-6. PubMed ID: 9852977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
